Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2006; 12(8): 1165-1174
Published online Feb 28, 2006. doi: 10.3748/wjg.v12.i8.1165
Published online Feb 28, 2006. doi: 10.3748/wjg.v12.i8.1165
| Thrombophilic condition | Relative risk of thrombosis |
| Inherited | |
| Heterozygote deficiency of natural anticoagulants (PC, PS, AT) | 10-fold |
| Heterozygote FVLM | 5-8 fold |
| Homozygote FVLM | 50-80 fold |
| Heterozygote PM | 2-4 fold |
| Homozygote PM | 10-fold |
| Acquired | |
| Oral contraceptive use | 4-fold |
| Surgery | 6-fold |
| Immobilization | 11-fold |
| Anti-phospholipid syndrome | 10-fold |
| Combined | |
| Oral contraceptive use + Heterozygote FVLM | 35-fold |
Table 2 Role of genetic thrombophilic factors in development of PVT
| Thrombophilicfactor | Chamouradet al[41] | Egeselet al[40] | Janssenet al[39] | Denningeret al[33] | Primignaniet al[38] |
| n | 10 | 32 | 92 | 36 | 65 |
| FVLM | 10 | 30 | 8 | 2,8 | 3 |
| PM | 40 | NS1 | 3 | 14 | 22 |
| PC deficiency | NS | 26 | 7 | 0 | 0 |
| PS deficiency | NS | 43 | 2 | 30 | 2 |
| AT deficiency | NS | 26 | 1 | 4,5 | 3 |
- Citation: Bayraktar Y, Harmanci O. Etiology and consequences of thrombosis in abdominal vessels. World J Gastroenterol 2006; 12(8): 1165-1174
- URL: https://www.wjgnet.com/1007-9327/full/v12/i8/1165.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i8.1165
